A complete work-up (contrast-enhanced CT of chest–abdomen–pelvis, brain MRI for TSC stigmata, and TSC1/2 gene testing) is warranted in any reproductive-age woman presenting with AML ≥ 4 cm. This evidence concerns the gene TSC1 and tuberous sclerosis.